SILICON LABORATORIES INC
For the period ended Dec 28, 2024. Filed Feb 4, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 4, 2025
SLAB$221.61-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of for the fiscal years ended and
Consolidated Statements of Operations
(In thousands, except per share data)
| Year Ended | |||
|---|---|---|---|
| December 28,2024 | December 30,2023 | December 31,2022 | |
| Revenues | $584,386 | $782,258 | $1,024,106 |
| Cost of revenues | 272,198 | 321,672 | 381,549 |
| Gross profit | 312,188 | 460,586 | 642,557 |
| Operating expenses: | |||
| Research and development | 332,225 | 337,744 | 332,326 |
| Selling, general and administrative | 145,453 | 146,996 | 190,971 |
| Operating expenses | 477,678 | 484,740 | 523,297 |
| Operating income (loss) | (165,490) | (24,154) | 119,260 |
| Other income (expense): | |||
| Interest income and other, net | 11,987 | 19,165 | 13,915 |
| Interest expense | (1,310) | (5,554) | (6,723) |
| Income (loss) before income taxes | (154,813) | (10,543) | 126,452 |
| Provision for income taxes | 36,197 | 7,943 | 38,450 |
| Equity-method earnings (loss) | — | (16,030) | 3,400 |
| Net income (loss) | $(191,010) | $(34,516) | $91,402 |
| Earnings (loss) per share: | |||
| Basic | $(5.93) | $(1.09) | $2.61 |
| Diluted | $(5.93) | $(1.09) | $2.54 |
| Weighted-average common shares outstanding: | |||
| Basic | 32,191 | 31,804 | 35,086 |
| Diluted | 32,191 | 31,804 | 36,042 |
Consolidated Statements of Comprehensive Income (Loss)
| Year Ended | |||
|---|---|---|---|
| December 28,2024 | December 30,2023 | December 31,2022 | |
| Net income (loss) | $(191,010) | $(34,516) | $91,402 |
| Other comprehensive income (loss), before tax: | |||
| Net changes to available-for-sale securities: | |||
| Unrealized gains (losses) arising during the period | 1,277 | 7,709 | (12,562) |
| Reclassification for losses included in net income (loss) | 41 | 4,596 | 2,088 |
| Net changes to cash flow hedges: | |||
| Unrealized gains (losses) arising during the period | 684 | 210 | (4,110) |
| Reclassification for losses (gains) included in net income (loss) | (644) | (250) | 4,110 |
| Other comprehensive income (loss), before tax | 1,358 | 12,265 | (10,474) |
| Provision (benefit) for income taxes | 263 | 2,602 | (2,205) |
| Other comprehensive income (loss) | 1,095 | 9,663 | (8,269) |
| Comprehensive income (loss) | $(189,915) | $(24,853) | $83,133 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.